The National Institute of Allergy and Infectious Diseases (NIAID) announced in September that it was preparing to conduct a clinical trial of the H1N1 influenza vaccine involving pregnant women. This is welcome news since pregnant women have been identified as a priority group for receiving the vaccine in the United States and in Canada.
Bioethics Forum
No comments:
Post a Comment